Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
Happy tax day and welcome to the latest edition of Merger Arbitrage Mondays. Merger activity increased last week with four new deals announced and two pending deals closing. We made a mistake last week when we indicated that the acquisition of Versum Materials (VSM) by Entegris (ENTG) closed...
Merck KGaA ( OTCPK:MKGAF ) says it signed a definitive agreement to acquire Versum Materials (NYSE: VSM ) for $53/share in cash, after VSM ended its prior merger deal with Entegris (NASDAQ: ENTG ). More news on: MERCK Kommanditgesellschaft auf Aktien, Versum Materials, Inc., Entegris, ...
Versum Materials (NYSE: VSM ) says Merck KGaA ( OTCPK:MKGAF ) has offered to acquire the company for $53/share, raised from its previous $48/share bid, and that its board determined that the bid is a superior proposal to its planned all-stock merger with Entegris (NASDAQ: ENTG ). More ne...
• €150 million investment over the 2019-2023 period in manufacturing site at Aubonne, Switzerland • Expansion supports growth of current and future portfolio of Merck's biotech medicines for patients around the world AUBONNE, Switzerland , March 28, 201...
Merck KGaA ( OTCPK:MKGAF ) formally launches a full takeover bid for Versum Materials (NYSE: VSM ) for $48/share, after a previous deal proposal for the same price was rejected by VSM management. More news on: MERCK Kommanditgesellschaft auf Aktien, Versum Materials, Inc., Entegris, Inc....
Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. AbbVie And Roche Have Trouble With Venclexta As Partial Clinical Hold Is Placed News: Recently, AbbVie ( ABBV ) and Roche ( RHHBY ) announced tha...
Merck KGaA (MKGAF) Full Year 2018 Earnings Conference Call March 7, 2019 8:00 AM ET Company Participants Constantin Fest – Head-Investor Relations Stefan Oschmann – Chief Executive Officer Marcus Kuhnert – Chief Financial Officer Conference Call Participan...
Merck KGaA ( OTCPK:MKGAF ): Q4 GAAP EPS of €1.22. More news on: Merck KGaA, Merck KGaA ADR, MERCK KGAA SPNS/ADR, Earnings news and commentary, Healthcare stocks news, Read more ...
Merck KGaA ( OTCPK:MKGAF ) says it remains committed to pursuing its acquisition of Versum Materials (NYSE: VSM ) and asks VSM shareholders to press management to consider its rejected takeover offer. More news on: Versum Materials, Entegris, Inc., Merck KGaA, Commodities news, Merger ...
Germany's Merck ([[MKGAF]], [[MKKGY]]) is chipping into the aggressive M&A game. The drugs and specialty chemical supplier is making an unsolicited $5.2 billion offer for Versum Materials ([[VSM]]). It's the second big cross-border deal in as many days hoping to nix an agreed tie-up. It's ...
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...